Molecular features of penicillin allergy

Journal of Investigative Dermatology

Volumn 110, Issue 3, 1998, Pages 203-206

  Weltzien, Hans Ulrich ^a   Padovan, Elisabetta ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Haptens; Penicilloyl peptides; T cell

Indexed keywords

CARRIER PROTEIN; HAPTEN; IMMUNOGLOBULIN E; PENICILLIN G; PENICILLOYL POLYLYSINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; DRUG HYPERSENSITIVITY; HELPER CELL; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PENICILLIN ALLERGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0031938078     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00122.x     Document Type: Review

References (32)

1. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes, Nature 383:787-793, 1996
2. Batchelor FR, Janet MD, Gazzard D: Penicillin allergy: the formation of the penicilloyl determinant. Nature 206:362-364, 1965
3. Brander C, Mauri-Hellweg D, Bettens F, Rolli HP, Goldman M, Pichler WJ: Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicilln-allergic individuals. J Immunol 155:2670-2680, 1995
4. Coleman JW: Keeping up with drug allergy. Clin Exp Allergy 26:1341-1342, 1996
5. + T cell responses: the alternative approches. Annu Rev Immunol 15:297-322, 1997
6. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-140, 1996
7. Garcia KC, Degano M, Stanfield RL, et al: An αβ T cell receptor structure at 2.5Ä and its orientation in the TCR-MHC complex. Science 274:209-219, 1996
8. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F: Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197-203, 1993
9. Hertl M, Merk HF: Lymphocyte activation in coutaneous drug reactions. J Invest Dermatol 105:95s-98s, 1995
10. + T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 101:794-799, 1993
11. Kalish RS, La Porte A, Wood JA, Johnson KL: Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 94:465-472, 1994
12. Lepoittevin JP, Leblond I: Hapten-peptide-T cell receptor interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 7:151-154, 1997
13. Levine BB, Redmond AP: Minor haptenic determinant-specific reagents of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 35:445-449, 1969
14. d-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity 3:51-63, 1995
15. Martin S, Weltzien HU: T cell recognition of haptens: a molecular view. Int Arch Allergy Immunol 104:10-16, 1994
16. + T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 155:462-472, 1995
17. McNicoll JM, Withworth WC, Oftung F, et al: Structural requirement of peptide and MHC for DR (α,β1*0401) -restricted T cell antigen recognition. J Immunol 155:1951-1963, 1995
18. Merk HF, Hertl M: Immunologic mechanisms of cutaneous drug reactions. Seminars in Coutaneous Med Surg 15:228-235, 1996
19. Mossmann TR, Sad S: The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
20. Murphy E, Shibuya K, Hosken NA, et al: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 183:901-913, 1996
21. Nalefski EA, Rao A: Nature of the ligand recognized by a hapten-specific and cirrier-specific, MHC-restricted T cell receptor. J Immmunol 150:3806-3816, 1993
22. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU: T cell recognition of penicillin G. structural features determining antigenic specificity. Eur J Immunol 26:42-48, 1996
23. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU: Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy, Eur J Immunol 27:1303-1307, 1997
24. Park BK, Coleman JW, Kitteringham NR: Drug disposition and drug hypersensitivity. Biochem Pharmacol 36:581-560, 1987
25. Preckel T, Grimm R, Martin S, Weltzien HU: Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cell and block intenalization of hapten-specific receptors. J Exp Med 185:1803-1813, 1997
26. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
27. Stern LJ, Brown JH, Jardesky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221, 1994
28. Sullivan TJ:. Drug allergy. In: Middleton E, Reed CE, Ellis EF, Franklin Adkinson N, Yunginger JW, Busse WW (eds). Allergy. Mosby-Year Book, St Louis, 1993, pp 1726-1746
29. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665-675, 1995
30. Verreck FAW, de Poel A, Drijfhout JW, Amons R, Coligan JE, Konmg F: Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DRI1, DRI3, and DR52. Immunogenetics 43:392-397, 1996
31. Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J: T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicol 107:141-151, 1995
32. Zanni MP, Mauri-Hellweg D, Brander C, et al: Characterization of lidocaine-specific T cells. J Immunol 158:1139-1148, 1997